BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alaimo G, Marco VD, Ferraro D, Stefano RD, Porrovecchio S, D’Angelo F, Calvaruso V, Craxì A, Almasio PL. Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: A randomized controlled trial. World J Gastroenterol 2006; 12(42): 6861-6864 [PMID: 17106937 DOI: 10.3748/wjg.v12.i42.6861]
URL: https://www.wjgnet.com/1007-9327/full/v12/i42/6861.htm
Number Citing Articles
1
Seyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2010; 66(11): 1071 doi: 10.1007/s00228-010-0881-7
2
Zaigham Abbas, Ghiasun Nabi Tayyab, Mustafa Qureshi, Mohammad Sadik Memon, Amna Subhan, Tanzila Shakir, Wasim Jafri, Saeed Hamid. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus RibavirinHepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14146
3
C. Fournier, C. Souvignet, P. Merle, P. Miailhes, P. Lack, C. Trepo. Traitement de l'hépatite CEMC - Hépatologie 2008; 3(1): 1 doi: 10.1016/S1155-1976(08)46513-0
4
Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson, Andrew K Burroughs. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD003617.pub2
5
Christopher M. Moore, Magdalena George, David H. Van Thiel. Consensus Interferon Used to Treat Prior Partial-Responders to Pegylated Interferon Plus RibavirinDigestive Diseases and Sciences 2011; 56(10): 3032 doi: 10.1007/s10620-011-1869-6